Latest Conference Coverage
Ozanimod Lowers ARR, Reduces Grey Matter Loss Compared to Interferon Beta-1a
September 11th 2019Data from the phase 3 SUNBEAM trial of the sphingosine 1-phosphate receptor modulator have suggested that the Celgene treatment lowers annualized relapse rates and reduces the rate of cortical gray matter loss, improving cognition measures, compared to IFN-ß1a.
R. Edward Hogan, MD: Diazepam Nasal Spray Offers Benefits and Long-Term Safety
September 10th 2019The director of the adult epilepsy center at Washington University in St. Louis spoke about the use of diazepam nasal spray in patients with epilepsy ­and detailed the advantages it offers these patients and their physicians.
Danielle Andrade, MD, MSc: Transitioning Patients With Epilepsy to Adult Care
September 10th 2019The professor of medicine, neurology, at the University of Toronto spoke to the hurdles faced by both pediatric and adult neurologists when transitioning a patient with epilepsy from childhood care to adult care.
Paul Durham, PhD: A Combination Approach With nVNS in Migraine
September 6th 2019The distinguished professor and director of cell biology at Missouri State University discussed the use of nVNS in migraine treatment and whether or not it can replace the use of or be used in conjunction with triptans—a medication on which many patients fail or report poor response on.
Trends in Migraine Care Reveal Treatment Gaps and Education Barriers
August 19th 2019The director of the MedStar Georgetown Headache Center and associate professor of neurology at MedStar Georgetown University Hospital discussed the ongoing efforts in drug development and what the ideal future may hold for migraine medicine.
Dementia Emergency Department Use Can Be Reduced With Specialized Telemedicine
August 17th 2019The professor of emergency medicine at the University of Wisconsin-Madison School of Medicine and Public Health discussed the impact that telemedicine, conducted in senior living communities, can have on emergency department visits for individuals with dementia.
Annette Langer-Gould, MD, PhD: Lowering Postpartum MS Relapse Rates With Breastfeeding
August 16th 2019The regional lead in clinical and translational neuroscience at Kaiser Permanente discussed subgroup findings from a study of pregnancy in women with MS which suggested that breastfeeding in the postpartum period can drastically decrease the risk of disease relapse.
Nina Riggins, MD, PhD: Predicting Outcomes of Botox Treatment in Chronic Migraine
August 14th 2019The assistant professor and neurologist at the University of California San Francisco discussed how the presence of cranial autonomic symptoms (CAS) can be a predictor of the effect of Botox on chronic migraine.
Joseph Berger, MD: Can AI Replace Neurologists?
August 14th 2019The associate chief of the MS division and professor of neurology at Penn Medicine spoke to neurologist’s reliance on physical examination, and how the use of almost-rudimentary but longstanding tools allow for critical 1-on-1 time with the patient.
Annette Langer-Gould, MD, PhD: No Increased Risk for Postpartum MS Relapses
August 13th 2019The regional lead in clinical and translational neuroscience at Kaiser Permanente spoke about the findings of a recent study of pregnancy in women with MS which showed no increased risk of relapse during the postpartum period.
Jeffrey L. Cummings, MD, ScD: Optimal Therapeutic Targets for Addressing Alzheimer Disease
August 13th 2019The director emeritus of the Cleveland Clinic Lou Ruvo Center for Brain Health and vice chair of the department of brain health at the University of Nevada Las Vegas spoke about therapies under investigation for the treatment of Alzheimer disease.
David Irwin, MD: Differentiating Dementias in Living Patients
August 12th 2019The assistant professor and cognitive neurologist at the University of Pennsylvania Frontotemporal Degeneration Center will share additional insights on Alzheimer disease at the upcoming International Congress on the Future of Neurology, taking place September 27-28, 2019 in New York City.
Kathryn Davis, MD, MSTR: Off-Label Clobazam Use in Refractory Epilepsy
August 9th 2019The associate professor of neurology and medical director of the epilepsy monitoring unit and Penn epilepsy surgical program at the University of Pennsylvania discussed the findings of a single-center review of off-label clobazam use for patients with drug-refractory epilepsy.
Kathryn Davis, MD, MSTR: Treatment Considerations for Women With Epilepsy
August 8th 2019The associate professor of neurology and medical director of the epilepsy monitoring unit and Penn epilepsy surgical program at the University of Pennsylvania shared insight into the prioritization of women with epilepsy who may intend to get pregnant.
Sarah Wilson, PhD: Long-Term Social Outcomes of Epilepsy Surgery
August 7th 2019The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne discussed the results of a study she and colleagues conducted in which they mapped the long-term social outcomes of patient post-epilepsy surgery.
Sarah Wilson, PhD: Managing Post-Operative Patients With Epilepsy
August 5th 2019The clinical neuropsychologist and head of the School of Psychological Sciences at the University of Melbourne detailed how the transition from states of illness to wellness after epilepsy surgery can result not just in brain changes, but psychosocial challenges for patients.
Can Telemedicine Make a Difference in Neurology Subspecialties?
August 5th 2019The staff neurologist at Cleveland Clinic’s Mellen Center for MS shared her insight into the use of telemedicine in an outpatient setting across a number of subspecialties in neurology and how it can supplement care going forward.
What Role Do Genetics Play in Determining Alzheimer Disease Risk?
August 2nd 2019The professor of neurology and founding chair of the John T. Macdonald Foundation Department of Human Genetics at the University of Miami discussed the distinctions between Alzheimer disease risk of ethnicities that share genetic markers.
